Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bevacizumab treatment followed by maintenance in life-threatening POEMS syndrome.

Bevacizumab treatment followed by maintenance in life-threatening POEMS syndrome. Ann Hematol. 2013 Aug; 92(8):1133-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.